Skip to main content
TipRanks
Go Ultimate75% OFF

Qlife Holding AB (4HG0) Stock Price & Analysis

2 Followers

4HG0 Stock Chart & Stats

€0.07-€0.01(-11.39%)
At close: 5:30 PM GMT+1
€0.2€0.21€0.22€0.23Jun 1Jun 2
Day’s Range
EUR 0.07 - EUR 0.07
52-Week Range
EUR 0.06 - EUR 0.28
Previous Close
EUR 0.08
Volume
N/A
Average Volume (3M)
0
Market Cap
EUR 2.55M
Enterprise Value
EUR 35.56M
Total Cash (Recent Filing)
EUR 1.90M
Total Debt (Recent Filing)
EUR 8.17M
Price to Earnings (P/E)
―
Beta
1.33
Next Earnings
Feb 10, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Point-of-care Diagnostic Platform

Qlife’s focus on point-of-care and near-patient testing addresses the need for faster, decentralized analysis outside centralized laboratories. If the platform gains adoption, this model can support recurring use across healthcare and other testing environments over multiple quarters.

Recurring Consumables Model

The combination of analyzers with single-use cartridges or reagents can create repeat purchasing as instruments are deployed. An installed-base-driven consumables stream may improve revenue visibility and deepen customer retention if the company expands utilization.

Historical Equity Strength

Positive shareholders’ equity in 2021–2022 shows that Qlife has previously operated with a stronger capital base than its recent position. Although later deterioration is a major concern, this history indicates the balance sheet has not always been structurally impaired.

Bears Say

Negative Equity And Debt

Negative equity combined with debt materially reduces financial flexibility and leaves fewer internal resources to absorb operating setbacks. This capital structure can increase dependence on recapitalization or external funding and constrain investment in commercial expansion.

Persistent Cash Burn

Ongoing negative operating and free cash flow indicates that the business is not currently self-funding its operations. Continued cash burn can require external financing, limit strategic flexibility, and increase execution risk while the company seeks to scale.

Unprofitable And Contracting Operations

Small and declining revenue alongside deeply negative profitability shows that Qlife has not yet reached a sustainable cost structure. Persistent losses weaken the capacity to reinvest internally and make future growth dependent on improving scale, margins, or funding access.

4HG0 FAQ

What was Qlife Holding AB’s price range in the past 12 months?
Qlife Holding AB lowest stock price was €0.06 and its highest was €0.28 in the past 12 months.
What is Qlife Holding AB’s market cap?
Qlife Holding AB’s market cap is €2.55M.
When is Qlife Holding AB’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Qlife Holding AB’s earnings last quarter?
Qlife Holding AB released its earnings results on Nov 11, 2026. The company reported -€0.017 earnings per share for the quarter.
Is Qlife Holding AB overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Qlife Holding AB pay dividends?
Qlife Holding AB does not currently pay dividends.
What is Qlife Holding AB’s EPS estimate?
Qlife Holding AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Qlife Holding AB have?
Qlife Holding AB has 28,874,178 shares outstanding.
What happened to Qlife Holding AB’s price movement after its last earnings report?
Qlife Holding AB reported an EPS of -€0.017 in its last earnings report. Following the earnings report the stock price went up 23.438%.
Which hedge fund is a major shareholder of Qlife Holding AB?
Currently, no hedge funds are holding shares in DE:4HG0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology